PAUSE Act Ill-Serves Patients

For 25 years, the 340B Drug Pricing Program has made a difference in the lives of millions of Americans. The relatively unknown program, started in 1992, reduces the cost of drugs for many hospitals and providers who serve low-income, underinsured or uninsured patients. It was simple: Drug manufacturers discounted outpatient drugs for these entities in…

All Harm, No Help in 340B Cuts

Now that a U.S. District Court has postponed the hospital industry’s legal challenge to cutbacks in the 340B drug discount program, it falls to Congress to reverse the Trump administration’s egregious new rules. Believe it or not, there’s hope, since the new rules benefit no one—quite literally. Legislation reversing them has even gained bipartisan backing…

House Gears Up for 340B Oversight Push

Pressure over the status of a federal drug discount program has intensified on Capitol Hill as Medicare reimbursement cuts for 340B hospitals have officially gone into effect. On Friday, a federal court dismissed several hospital associations’ suit that sought to block the cuts and lawmakers geared up for a legislative battle that has grown increasingly…